Cargando…
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
The androgen receptor (AR) is the principal therapeutic target in prostate cancer. For the past 70 years, androgen deprivation therapy (ADT) has been the major therapeutic focus. However, some patients do not benefit, and those tumors that do initially respond to ADT eventually progress. One recentl...
Autores principales: | Gao, Lina, Schwartzman, Jacob, Gibbs, Angela, Lisac, Robert, Kleinschmidt, Richard, Wilmot, Beth, Bottomly, Daniel, Coleman, Ilsa, Nelson, Peter, McWeeney, Shannon, Alumkal, Joshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660401/ https://www.ncbi.nlm.nih.gov/pubmed/23704919 http://dx.doi.org/10.1371/journal.pone.0063563 |
Ejemplares similares
-
plethy: management of whole body plethysmography data in R
por: Bottomly, Daniel, et al.
Publicado: (2015) -
HitWalker2: visual analytics for precision medicine and beyond
por: Bottomly, Daniel, et al.
Publicado: (2016) -
HitWalker: variant prioritization for personalized functional cancer genomics
por: Bottomly, Daniel, et al.
Publicado: (2013) -
The genetics of gene expression in complex mouse crosses as a tool to study the molecular underpinnings of behavior traits
por: Hitzemann, Robert, et al.
Publicado: (2013) -
Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine
por: Bottomly, Daniel, et al.
Publicado: (2013)